Gland Pharma Walk-in Interview 2021 B.Sc, B.Pharma, M.Sc, M.Pharma candidates can apply for Production, IPQA & Microbiology At Pashamylaram(Sangareddy).Gland Pharma Notification full detailes below.Interested and eligible candidates can attend interview on scheduled time and venue.
- Vacancy details:
- Post Name: Production, IPQA & Microbiology
- Qualification: B.Sc, B.Pharma, M.Sc, M.Pharma candidates can apply
- Experience:1 to 7 years
Job Description: Gland Pharma Hiring For Production, IPQA & Microbiology !
Important Details :
- Post of date: 01/11/2021
- Selection Process: The selection will be on the basis of Interview.
Walk-in Interview Production, IPQA & Microbiology , Gland Pharma
- Date :2nd Nov 2021, between 9:00 AM-12:30 PM
- Venue: Gland Pharma Unit 2, Plot No: 42-52., Phase III, TSIIC. Pashamylaram. Patancheru, Pashamylaram(Sangareddy), Medak, Telangana, India
2nd November @ Gland Pharma Unit 2, Pashamylaram | Experience: 1-7 years | Immediate Joiners Preferred | Parenteral Experience Mandatory
Production. : Hands on experience in Vial Filling/ Vial Sealing/Line Chemist/Compounding/Autoclave operation. · Sterile injectable experience is mandatory. · Experience in Line management, QMS, CIP, SIP, Autoclave, PFS, BPCR · Willing to work in any shifts
Microbiology: Microbiology testing and Environmental monitoring Experience in BET MLT, Microbiology Testing Media dispensing for media fill trials. Maintaining related raw data and log books. Maintaining Good Laboratory Practices. Willing to work in any shifts
IPQA: 1-6 years formulation injectable experience in “In process Quality assurance” Experience in Quality assurance Manufacturing activities. Responsible for Media Fill, Cleaning Validation, Finished Product Sampling Proccess Validation, Bulk Sampling, Line Clearance, Production Line Monitoring Willing to work in any shifts
Mandatory Documents: 10th,12th , UG, PG marks memo, Last three months’ Salary slips, Latest Increment Letter/CTC letter, Last three months Bank Statement
A holistic objective of dispensing health through a portfolio of injectable products across various therapeutic segments and delivery systems, has helped us expand to seven manufacturing facilities in India, with a capacity of approximately 750 million units. These include four facilities with 22 production lines for finished formulations and three Active Pharmaceutical Ingredient (API) facilities.